Description
Angiomax is a prescription drug manufactured by The Medicine Company. It is also known as Bivalirudin. It is a direct thrombin inhibitor indicated for use as an anticoagulant in patients. It is for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
- Undergoing percutaneous coronary intervention (PCI) with provisional use of glycoprotein IIb/IIIa
inhibitor (GPI) - With, or at risk of, heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia
and thrombosis syndrome (HITTS), undergoing PCI - With unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA)